Pay in 4 interest-free payments of $5.54 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Ruxolitinib cream, the first JAK inhibitor approved for vitiligo, demonstrated in phase 3 studies (TRuE-V) that approximately 30% of patients achieved repigmentation of more than 75% of the face after 52 weeks
Regeneration & Healing : PDRN accelerates skin regeneration, improving texture and tone
Targeted Supplements to Discuss with Your Provider N-acetylcysteine (NAC): A direct precursor to cysteine and glutathione
Ordering was easy and delivery pretty quick
We also include supporting ingredients like Alpha Lipoic Acid and COQ10 in our formulations
US$ 21.65
US$ 25.98
US$ 29.17
